J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 7,740.00
+20.00 (0.26%)
At close: Mar 13, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 45.26 billion as of March 13, 2026. Its market cap has decreased by -11.00% in one year.
Market Cap
45.26B
Enterprise Value
35.04B
Revenue
31.12B
Ranking
n/a
PE Ratio
19.98
Stock Price
7,740.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 45.26B, a decrease of -68.77%. That is a compound annual growth rate of -44.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 45.26B | -10.00% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pep | 65.89B |
| EyeGene | 63.16B |
| SunBio,Inc. | 60.78B |
| Aptamer Sciences | 55.68B |
| NGeneBio | 53.67B |
| SCM Lifescience | 37.31B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |